Targeting the Phosphatidylinositol 3-Kinase Pathway in Multiple Myeloma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2921
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phosphatidylinositol-3-Kinase Pathway

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

TIPE2 Controls Innate Immunity to RNA by Targeting the Phosphatidylinositol 3-Kinase-Rac Pathway

Journal of Immunology
AllergyImmunology
2012English

An SH2-domain-containing Kinase Negatively Regulates the Phosphatidylinositol-3 Kinase Pathway

Genes and Development
GeneticsDevelopmental Biology
2001English

Extracellular Zinc Activates P70 S6 Kinase Through the Phosphatidylinositol 3-Kinase Signaling Pathway

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Targeting the Fanconi Anemia/Brca Pathway Circumvents Drug Resistance in Multiple Myeloma

Cancer Research
Cancer ResearchOncology
2009English

The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

New Role for SHC in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Targeting the Pim Kinases in Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy